Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001209191-21-068851

Options or other derivatives

  • Chief Operating Officer acquired 406,020 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lecault Veronique Chief Operating Officer 2021-12-07 Grant or award · Share Option +406,020 2,930,154 D
Loading xslF345X03/doc4.xml…